Zimberelimab

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name

Zimberelimab

DrugBank Accession Number

DB17505

Background

Not Available

Type

Biotech

Groups

Investigational

Synonyms

Anti-pd-1 monoclonal antibody gls-010
Immunoglobulin g4(231-proline), anti-(human programmed cell death protein 1) (human monoclonal ab122 .gamma.4-chain), disulfide with human monoclonal ab122 .lambda.-chain, dimer

External IDs

Indication: Not Available
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings: Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics: Not Available
Mechanism of action: Not Available
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Not Available
Half-life: Not Available
Clearance: Not Available
Adverse Effects: Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity: Not Available
Pathways: Not Available
Pharmacogenomic Effects/ADRs: Not Available

Drug Interactions: This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions: Not Available

Clinical Trials

Phase	Status	Purpose	Conditions	Count
3	Not Yet Recruiting	Treatment	Classical Hodgkin's Lymphoma / Recurrent Classical Hodgkin Lymphoma / Refractory Classical Hodgkin's Lymphoma	1
3	Not Yet Recruiting	Treatment	Persistent, Recurrent, or Metastatic Cervical Cancer	1
3	Recruiting	Treatment	Advanced Upper Gastrointestinal Tract Adenocarcinoma	1
3	Recruiting	Treatment	Lung Cancer / Non-Small Cell Lung Cancer (NSCLC) / Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) / Squamous Cell Non-small Cell Lung Cancer	1
3	Recruiting	Treatment	Non-Small Cell Lung Cancer (NSCLC)	1
2	Active Not Recruiting	Treatment	Lung Cancer / Non-Small Cell Lung Cancer (NSCLC) / Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) / Squamous Cell Non-small Cell Lung Cancer	1
2	Completed	Treatment	Metastatic Castration-Resistant Prostate Cancer (mCRPC) / Prostate Cancer	1
2	Not Yet Recruiting	Treatment	Bile Duct Cancer / Biliary Tract Carcinoma / Cholangiocarcinoma	1
2	Not Yet Recruiting	Treatment	Cervical Cancer	1
2	Not Yet Recruiting	Treatment	Cervical Cancer / Cervical Carcinoma	1

Drug created at February 09, 2023 19:36 / Updated at February 10, 2023 08:55